The Camden Group Launches Mobile App for Healthcare Providers to Get Lean by Tracking Workflows and EMR Efficiency

Los Angeles, California, August 27, 2015 – In response to the need for healthcare providers to improve performance and efficiency as a result of healthcare reform, The Camden Group, (www.thecamdengroup.com), a national healthcare business advisory firm, has launched AccuTracker, a new mobile software that helps track cycle times and electronic medical records (EMR) use. Using AccuTracker, organizations are better able to apply Lean and Six Sigma principles to identify and reduce inefficiencies in their workflows and optimize performance.

Developed by the performance improvement experts at The Camden Group, AccuTracker (www.thecamdengroup.com/accutracker) is an easy-to-use mobile app that allows users to capture cycle times for clinical processes (e.g., medical practices, urgent care centers, operating rooms, emergency departments) as well as non-clinical processes, such as revenue cycle management, all from the convenience of a phone or tablet. This data is hosted on secure servers and exportable in editable CSV files. Whether the organization is a small clinic or a multi-hospital health system, the app enables the organization to quickly identify breakdowns, bottlenecks, and waste in day-to-day workflows. Over time, as more data is collected and aggregated, AccuTracker will also allow users to benchmark and compare performance against other organizations to help identify areas for improvement. In addition, there is a built-in module which helps assess the efficiency of the EMR through the tracking of mouse clicks, screen views, and the amount of typing in the EMR. This module also documents how long providers spend on each component of the patient visit.

“In this new value-based healthcare environment, efficiency is critical to achieving success,” says Steven T. Valentine, president of The Camden Group. “With AccuTracker, healthcare providers can increase patient and physician satisfaction by improving workflow and performance – avoiding unnecessary wait times and redundancies.”

Most recently, The Camden Group assisted in a major workflow assessment initiative for a large independent primary care medical group with approximately 500 physicians in 200 primary care and 9 urgent care sites through the country. By using AccuTracker to perform time and efficiency studies in 50 locations, a potential time savings of an average of one hour per day per physician was identified.

For more information on AccuTracker, visit www.thecamdengroup.com/accutracker.

About The Camden Group
With offices across the country, The Camden Group is one of the nation’s leading healthcare business advisory firms. The firm provides a broad array of healthcare consulting services to enable organizational, clinical, and operational transformation to respond to the rapidly changing healthcare environment.  This includes services such as strategic and business planning; performance improvement; care model redesign and access improvement; physician compensation; mergers, acquisitions, and other transactions; physician-hospital alignment; clinical integration; payer strategy; and implementing accountable care organizations. Since its founding in 1970, The Camden Group has advised more than 2,000 health systems, medical groups, hospitals, outpatient facilities, post-acute providers, and other healthcare organizations nationwide. For more information, visit us online at www.TheCamdenGroup.com.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.